Throat Cancer Treatment Market, Global Outlook and Forecast 2024-2031

Throat cancer refers to cancerous tumors that develop in throat (pharynx), voice box (larynx) or tonsils.
This report contains market size and forecasts of Throat Cancer Treatment in Global, including the following market information:
Global Throat Cancer Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Throat Cancer Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pharyngeal Cancer Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Throat Cancer Treatment include Bristol Myers Squibb, Hospira Inc, Baxter International Inc, Teva Pharmaceutical Industries Ltd, Mylan Pharmaceuticals Inc, APP Pharmaceuticals, LLC, Sanofi, Intas Pharmaceuticals Ltd and Amgen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Throat Cancer Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Throat Cancer Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Throat Cancer Treatment Market Segment Percentages, by Type, 2021 (%)
Pharyngeal Cancer
Laryngeal Cancer
Global Throat Cancer Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Throat Cancer Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Clinics
Others
Global Throat Cancer Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Throat Cancer Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Throat Cancer Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Throat Cancer Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bristol Myers Squibb
Hospira Inc
Baxter International Inc
Teva Pharmaceutical Industries Ltd
Mylan Pharmaceuticals Inc
APP Pharmaceuticals, LLC
Sanofi
Intas Pharmaceuticals Ltd
Amgen
Celgene
Eli Lilly and Company
Pfizer Inc.